journal
Journals Immunology and Allergy Clinics...

Immunology and Allergy Clinics of North America

https://read.qxmd.com/read/36411011/-doctor%C3%A2-i-m-pregnant
#1
EDITORIAL
Edward S Schulman
No abstract text is available yet for this article.
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411010/status-asthmaticus-gravidus-emergency-and-critical-care-management-of-acute-severe-asthma-during-pregnancy
#2
REVIEW
Charles B Cairns, Monica Kraft
One-third of women with asthma have deterioration of their asthma during pregnancy, and one-fourth of pregnant women with asthma will experience severe exacerbations necessitating emergency department (ED) visits or hospitalizations. Early recognition of acute severe asthma, including life-threatening status asthmaticus, and aggressive medical interventions with β2-agonists, anticholinergic agents, and systemic corticosteroids are necessary to treat maternal airway bronchoconstriction, support maternal and fetal oxygenation, and avoid adverse fetal outcomes...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411009/chronic-management-of-asthma-during-pregnancy
#3
REVIEW
Jennifer A Namazy, Michael Schatz
Asthma is one of the most common potentially serious medical problems to complicate pregnancy. Optimal management of asthma during pregnancy is thus important for both mother and baby. Treating asthmatic women requires understanding the effects of pregnancy on the course of asthma, and, conversely, the effects of asthma on pregnancy outcomes. Successful management also requires an understanding the barriers to asthma control in this population of patients. Evidence has shown that it is essential that the allergist-immunologist, obstetrician, and patient work as a team during pregnancy to achieve optimal maternal and neonatal outcomes...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411008/management-of-the-upper-airway-distress-during-pregnancy
#4
REVIEW
Jean Kim, Michael Z Cheng, Robert Naclerio
Pregnancy can induce significant upper airway distress in women by the induction of rhinitis of pregnancy (ROP). Pregnancy can also exacerbate underlying rhinopathies. Little is known regarding the pathophysiology of the ROP. Diagnosis of other coexistent rhinopathies is key. Treatment regimens closely mirror standard treatments for other rhinopathies that are independent of pregnancy and are generally accepted as safe. Early recognition of the progression of rhinitis in the pregnant patient into complications of rhinosinusitis is important to prevent harm to both mother and fetus...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411007/advancing-exposomic-research-in-prenatal-respiratory-disease-programming
#5
REVIEW
Rosalind J Wright
Disease programming reflects interactions between genes and the environment. Unlike the genome, environmental exposures and our response to exposures change over time. Starting in utero, the respiratory system and related processes develop sequentially in a carefully timed cascade, thus effects depend on both exposure dose and timing. A multitude of environmental and microbial exposures influence respiratory disease programming. Effects result from toxin-induced shifts in a host of molecular, cellular, and physiologic states and their interacting systems...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411006/maternal-macro-and-micronutrient-intake-during-pregnancy-does-it-affect-allergic-predisposition-in-offspring
#6
REVIEW
Katherine Stumpf, Julie Mirpuri
This review article explores the available literature on the association of maternal nutrient intake with development of allergies in offspring. It examines the mechanisms for maternal diet-mediated effects on offspring immunity and dissects recent human and animal studies that evaluate the role of both maternal macro- and micronutrient intake on offspring susceptibility to asthma, eczema, food allergy, and atopy.
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411005/improving-asthma-outcomes-during-pregnancy-in-underserved-communities
#7
REVIEW
Alan Gandler, Edward S Schulman, Erika J Yoo
It is known that poor asthma control is common in pregnancy, and asthma in general disproportionally affects underserved communities. However, there is a paucity of data examining strategies to improve asthma control specifically among pregnant women from vulnerable populations. Identified barriers to optimal asthma care in other underserved groups include health literacy, financial constraints, cultural differences, and poor environmental controls. These deficiencies may also be targets for multimodal interventions geared toward improving asthma outcomes for underserved women during pregnancy...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411004/monoclonal-antibodies-biologics-for-allergic-rhinitis-asthma-and-atopic-dermatitis-during-pregnancy-and-lactation
#8
REVIEW
Courtney L Ramos, Jennifer Namazy
Asthma, allergic rhinitis, chronic urticaria, and atopic dermatitis are common diseases that affect hundreds of thousands of pregnant women each year. The authors discuss the use of biologics in women who are pregnant or lactating, indications, available safety information, and knowledge gaps. There are pregnant patients for which standard treatment is either inadequate or contraindicated; in those cases, monoclonal antibodies (biologics) should be considered despite the unknown risk to the fetus. In severe asthma, omalizumab is the best studied with reassuring available safety data...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411003/longitudinal-changes-in-upper-and-lower-airway-function-in-pregnancy
#9
REVIEW
Vanessa E Murphy, Megan E Jensen
Physiologic changes during pregnancy have implications for both upper and lower airway function. Upper airway resistance increases, and total lung capacity decreases. Upper airway symptoms increase; some women develop pregnancy-induced rhinitis and there is an increased prevalence of sleep-disordered breathing compared to prepregnancy. Longitudinal studies examining changes in upper and lower airway function parameters are limited, particularly in women with asthma. Some studies have observed reduced lung function with advancing gestation; however, changes are small and unlikely to be of major clinical significance...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411002/use-of-asthma-medication-during-gestation-and-risk-of-specific-congenital-anomalies
#10
REVIEW
Ruth P Cusack, Christiane E Whetstone, Gail M Gauvreau
Poorly controlled asthma can affect neonatal outcomes including congenital anomalies, which can be reduced with appropriate asthma care during pregnancy. Although there is a concern regarding the safety of asthma medication use during pregnancy and congenital anomalies, the risk of uncontrolled asthma outweighs any potential risks of controller and reliever medication use. Patient education before and during pregnancy is critical to ensure good compliance to therapy and reduce the risk of poor asthma control...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411001/mastocytosis-in-pregnancy
#11
REVIEW
Nonie Arora, Cem Akin, Anna Kovalszki
Mastocytosis is a rare neoplastic disorder of the mast cell lineage resulting in unregulated proliferation and activation of mast cells. Symptoms worsen in about one-third of pregnant patients. Treatment focuses on management of symptoms with antimediator therapy (H1 & H2 antihistamines, glucocorticoids, and epinephrine, if required). Medication selection requires care during labor and delivery. Although it is generally considered safe to use a medication patient tolerated before, some common medications may need to be avoided or used with caution (eg, codeine, morphine, nonsteroidal antiinflammatory drugs, vancomycin) if the patient does not have any history of exposure to them...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36411000/hereditary-angioedema-during-pregnancy-considerations-in-management
#12
REVIEW
Marc A Riedl
In recent years, hereditary angioedema (HAE) management has substantially advanced but also become more complex with additional therapeutic options. Pregnancy significantly influences the clinical symptoms of HAE in many women because of estrogen effects or other physiologic factors, and also introduces important safety concerns related to HAE medications. Management of HAE during pregnancy requires clinicians to be familiar with the potential clinical course, triggers, and recommended treatment strategies to provide guidance and optimal medical management to women and families affected by the condition...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36410999/primary-antibody-immunodeficiency-and-the-pregnant-patient
#13
REVIEW
Shouling Zhang, Charlotte Cunningham-Rundles
An overview of primary antibody immunodeficiency in pregnancy is presented. Indications for immunoglobulin replacement therapy (IGRT), dosing, and safety considerations are highlighted. Uses of immunizations and antimicrobial therapy are also discussed. In general, IGRT, both intravenous and subcutaneous, is considered safe in pregnancy.
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36410998/management-of-allergic-skin-disorders-in-pregnancy
#14
REVIEW
Eleanor M Pope, Leah Laageide, Lisa A Beck
The safe management of allergic skin disorders during pregnancy is essential to maternal and fetal health. Poorly controlled allergic skin disease affects the health of mother and child. This article reviews the disease course and treatment of atopic dermatitis, chronic urticaria, and allergic contact dermatitis in pregnancy. It focuses on topical and systemic therapies in the context of pregnancy and breastfeeding. Because disease activity may vary in pregnancy, prescription stewardship is imperative; a balance among disease control, minimum effective dosing, and medication safety profiles should be maintained...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36410997/anaphylaxis-in-pregnancy
#15
REVIEW
Margaret M Kuder, Rachael Baird, Maeve Hopkins, David M Lang
Anaphylaxis in pregnancy is a rare event, but has important implications for the pregnant patient and fetus. The epidemiology, pathophysiology, diagnosis, and treatment all carry important considerations unique to the pregnant patient. Common culprits of anaphylaxis are primarily medications, particularly antibiotics and anesthetic agents. Diagnosis can be difficult given the relative lack of cutaneous symptoms, and normal physiologic changes in pregnancy such as low blood pressure and tachycardia. Apart from patient positioning, treatment is similar to that of the general population, with a focus on prompt epinephrine administration...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36410996/gestational-development-of-the-human-immune-system
#16
REVIEW
Laura Jardine, Ina Schim van der Loeff, Iram J Haq, Thomas D R Sproat
Building an immune system is a monumental task critical to the survival of the fetus and newborn. A functional fetal immune system must complement the maternal immune system in handling in utero infection; abstain from damaging non-self-reactions that would compromise the materno-fetal interface; mobilize in response to infection and equip mucosal tissues for pathogen exposure at birth. There is growing appreciation that immune cells also have noncanonical roles in development and specifically may contribute to tissue morphogenesis...
February 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36265979/the-environment-critical-cornerstone-of-allergic-diseases
#17
EDITORIAL
Jill A Poole
No abstract text is available yet for this article.
November 2022: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36265978/influence-of-rural-environmental-factors-in-asthma
#18
REVIEW
Jennilee Luedders, Jill A Poole
PURPOSE: The objective of this article is to review recent literature on the implications of agricultural factors including pesticides, animal/livestock production facilities, agricultural dust, endotoxin, biomass/crop burning, and nutritional factors with respiratory health. METHODS: PubMed, Embase, and CINAHL literature searches for the years 2016 to 2021 were conducted with librarian assistance. RESULTS: Several studies suggest increased risk for asthma or wheeze with certain rural exposures, particularly for pesticides, livestock production facilities, agricultural dust, and biomass and crop burning...
November 2022: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36265977/air-pollution-effects-in-allergies-and-asthma
#19
REVIEW
Anil Nanda, Syed Shahzad Mustafa, Maria Castillo, Jonathan A Bernstein
Outdoor air pollution is associated with exacerbations of allergic diseases, including asthma, allergic rhinitis, and other atopic conditions. The increased allergic disease prevalence has been linked to this urbanization, industrialization, and economic growth globally. Air pollutants are well-known to disrupt the epithelium leading to specific diseases in any organ system that has epithelial linings. This review provides an overview of the health effects of air pollution on allergic disorders and specifically addresses how it may impact the epithelial barrier in the upper and lower respiratory tracts to facilitate the health effects associated with these exposures...
November 2022: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/36265976/electronic-cigarettes-and-vaping-in-allergic-and-asthmatic-disease
#20
REVIEW
Marissa Love, Selina Gierer
Electronic nicotine delivery systems (ENDS) were introduced in 2006, offering alternatives to combustible cigarettes. There is significant controversy regarding their sale and regulation, particularly with youth and high-risk patient populations. They were deemed a "major public health concern" by the United States (US) Surgeon General in 2016 . Already associated with health consequences, recently e-cig or vaping product use-associated lung injury (EVALI) has exposed their potential to cause life-threatening complications...
November 2022: Immunology and Allergy Clinics of North America
journal
journal
29830
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.